45-day, human-supervised Recovery Sprint

Patient Opportunity Intelligence

Managed recovery for dormant full-arch implant inquiries.

Explore the Patient Opportunity Demo
Observable evidence review
Human-supervised outreach
Practice-approved messaging
Patient Opportunity Intelligence
Imported
486
Reachable
311
Patient opportunities
94
Representative signal
María González

María González asked about full-arch implant financing in Spanish after earlier English-language follow-up, with no recorded opt-out.

Economic Problem

Dormant records are not cold if the evidence says otherwise.

Full-arch implant practices often pay to acquire patient inquiries that stall after financing questions, language mismatch, missed callbacks, or incomplete follow-up.

How Recovery Works

Dormant records become controlled handoffs.

01
Import dormant patient inquiry records
02
Normalize and validate fields
03
Exclude suppressed and ineligible records
04
Detect treatment-interest, financing, and language signals
05
Prepare human-reviewed recovery strategy
06
Route sensitive decisions to a Treatment Coordinator
07
Measure consultation outcomes
1
Dormant records
2
Opportunity intelligence
3
Recovery strategy
4
Controlled outreach
5
Treatment Coordinator

Product Intelligence

Explainable recovery logic, not a black box.

See how the system finds recoverable patient opportunities from observable inquiry evidence, preferred language, unresolved financing questions, and contact permission.

See how the system finds recoverable opportunities

The Sprint

45-Day Recovery Sprint

Week 1: Synthetic record import and opportunity classification
Weeks 2-3: Strategy preparation and practice review
Weeks 3-5: Simulated outreach and human handoff
Weeks 5-6: Consultation confirmation and outcome review
45 days
$4,000 flat
Historical lead-list analysis
Opportunity classification
Recovery strategy
Personalized outreach preparation
Human review controls
Simulated or approved operational handoff

Representative Case

María González

María González asked about full-arch implant financing in Spanish after earlier English-language follow-up, with no recorded opt-out.

Open Representative Case
Evidence: Observable prior treatment intent
Evidence: Recorded unresolved question
Evidence: Language match between outreach and preference
Evidence: Dormancy age
Evidence: Reachability and consent status
Evidence: Need for human coordinator handoff

Human Control

Designed for supervision, permission, and restraint.

Human-supervised recommendations
Practice approval before sensitive outreach
Permission and opt-out controls
Explainable source evidence
Synthetic public demo
Secure intake required before real patient data

All practices, patients, conversations and performance data shown here are synthetic. Real customer data requires secure intake, appropriate permissions, and client-defined suppression rules before any operational use.

Illustrative Economics

Adjustable assumptions, not a forecast.

486
Dormant records
94
Priority opportunities
$4,000 flat
Sprint fee

FAQ

Does the demo use real patient data?

No. The public demo uses synthetic patient records only.

Does Lockwood claim clinical eligibility or financing approval?

No. Clinical, pricing, financing, and scheduling specifics require practice review.

Is revenue guaranteed?

No. Outcomes are illustrative and not a forecast or guarantee.

Review the dormant opportunities already inside your records.

No guaranteed appointments, revenue, treatment acceptance, or financing approval.